Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nicholas Quercetti

Orthopaedic Surgery Wilmington, DE Doctor of Osteopathy

NPI 1235384561 CMS profile 1283048

1941 Limestone Rd, Ste 101, Wilmington, DE 19808

Open in the dashboard

General payments

$32,063

146 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nicholas Quercetti of Wilmington, DE is reported in the CMS Open Payments database as having received $32,063 across 146 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 85th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,133 40
2024 General $2,550 22
2023 General $5,220 19
2022 General $4,529 17
2021 General $3,925 20
2020 General $5,721 7
2019 General $4,985 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicholas Quercetti
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Nicholas Quercetti were reported at $5,133. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Nicholas Quercetti Orthopaedic Surgery median Middle half National median
2019 $4,985 $644 $140–$2,844 $163
2020 $5,721 $312 $75–$1,860 $114
2021 $3,925 $520 $117–$2,495 $132
2022 $4,529 $598 $128–$2,731 $149
2023 $5,220 $461 $128–$2,264 $160
2024 $2,550 $497 $134–$2,475 $164
2025 $5,133 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Synthes USA Products LLC $12,736 13 payments
  2. Synthes GmbH $6,429 6 payments
  3. Medical Device Business Services, Inc. $5,918 15 payments
  4. CurvaFix, Inc. $3,569 6 payments
  5. Stryker Corporation $1,642 28 payments
  6. DePuy Synthes Sales Inc. $922 46 payments
  7. SI-BONE, Inc. $138 5 payments
  8. Radius Health, Inc. $120 4 payments
  9. Integra LifeSciences Corporation $81 2 payments
  10. Smith+Nephew, Inc. $80 4 payments
  11. Other $429 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $17,888 8 payments
  2. Compensation for serving as faculty or as a speaker for a medical education program $4,500 3 payments
  3. Food and Beverage $3,750 127 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,232 2 payments
  5. Travel and Lodging $2,694 6 payments
Products named General payments · program years 2019–2025
  1. LCP $6,300 2 payments
  2. EX NAILS $6,300 3 payments
  3. NA Trauma $6,300 2 payments
  4. IM NAILS $6,300 3 payments
  5. CurvaFix IM Implant $3,569 6 payments
  6. VA-LCP PLATES & SCREWS $3,488 1 payment
  7. VA-LCP $1,628 18 payments
  8. TFN ADVANCED $656 9 payments
  9. PRO $489 3 payments
  10. NA Trauma $413 17 payments
  11. Other $2,526 82 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

14

Median for Orthopedic Surgery: 203

Drug cost

$56

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Tramadol Hcl Generic 14 $56

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 145 billing codes

Paid by Medicare

$233,868

Medicare's payments for the services billed

Medicare patients

272

Average age 77

Services billed

1,343

188 women, 84 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Depression 47%
Ischemic heart disease 39%
Chronic kidney disease 35%
Osteoporosis 35%
Diabetes 33%
Atrial fibrillation 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

146 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Delaware

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record